HOXA10 exerts an oncogenic role in several tumors, including ovarian clear cell adenocarcinoma, oral squamous cell carcinoma, prostate carcinoma and endometrial adenocarcinoma [23–25, 27]. Here, HOXA10 is linked to prostate carcinoma.